Categories: News

Nass Valley Gateway Looks Ahead After Q2 Growth

Nass Valley Gateway nearly doubled their sales QoQ this year after releasing their new product lines and innovative direct sales platform

VANCOUVER, BC, July 20, 2021 (GLOBE NEWSWIRE) — via NewMediaWire — Nass Valley Gateway LTD. (NVG), (CSE: “NVG.CN”); (OTC Pink: NSVGF) (Frankfurt: “3NVN”), distributor of top quality THC-free, broad and full spectrum CBD consumables, continues to build momentum from their quarterly growth into Q3 by analyzing their trending products while forming strong marketing partnerships. After a quarterly increase of 84.7% in online sales, Nass Valley Gateway identifies Pain Relief, Pet and Delta 8 products as their top 3 selling product categories. 

The most popular of each category are the pain relief Roll On Cooling Gel, cheese flavored Pet Chews, and Delta 8 Gummy Bears. Nass Valley has also seen more than double the growth on their hemp cigarettes and bath bombs. “The market is responding with excitement to our diverse product line. As people are becoming more aware of CBD and Delta 8, they are also looking to discover new ways to utilize it. We are able to offer a catalog of more than 60 products to meet the growing demand and the number,” states Michael Racaniello from the NVG Board of Directors. 

Nass Valley has initiated marketing partnerships with leading online platforms in the CBD, cannabis, and hemp space such as, Herb. Herb has over 80 million monthly video views, 14 million community members, and 41 million monthly engagements, which Nass Valley Gateway will leverage to help propel their brand to the mainstream. Nass Valley has also launched their new direct sales platform, Nass Valley Direct, a hybrid model focused on developing B2B, and B2C direct sales networks across the nation led by Jeff Rogers. Rogers is the founder and former CEO of Kannaway, the first company in the space who used a direct sales approach. “This model is a clear differentiator in the industry,” quotes Rogers. 

Michael Racaniello continues, “Our groundbreaking direct sales program has also been appealing to a wide audience. We provide innovative support for associates to expand our products within their personal circles as well as larger B2B opportunities, providing limitless mutual growth between themselves and the company.” 

ABOUT NASS VALLEY GATEWAY LTD: 

Nass Valley Gateway LTD (NVG) is a publicly traded company on the CSE, OTC Pink, and Frankfurt markets focused on the cultivation, extraction, and sales of organic, non-GMO, ALL NATURAL SEED, CBD products for human and pet consumption. Nass Valley CBD products are sold under the “Nass Valley Gardens” brand, an affiliate, via retail, wholesale, direct response, and digital sales channels.

We seek Safe Harbor. 

Neither the CSE nor its Regulation Services Provider has reviewed or accepts responsibility for the adequacy or accuracy of the contents of this news release. 

Company: Nass Valley Gateway Ltd. 

422 Richards Street, Suite 170 

V6B 2Z4 Vancouver 

Canada 

E-mail: info@nassvalleygateway.com 

Corporate Website: www.nassvalleygateway.com 

Product Website: www.nassvalleyproducts.com 

Investor Relations 

Michael Semler

+1 (609) 651-0032 

Michael.s@nassvalleygateway.com

Staff

Recent Posts

NervGen Pharma Announces Proposed Amendment to Warrants

Vancouver, British Columbia--(Newsfile Corp. - December 12, 2025) - NervGen Pharma Corp. (TSXV: NGEN) (OTCQB:…

10 hours ago

MyndTec Inc. Completes Ninth Tranche of Non-Brokered Private Placement

Mississauga, Ontario--(Newsfile Corp. - December 12, 2025) - MyndTec Inc. (CSE: MYTC) ("MyndTec" or the "Company"),…

12 hours ago

Dominari Holdings Announces Change of Record Date and Payment Date for $10 Million Cash Dividend

NEW YORK, Dec. 12, 2025 /PRNewswire/ -- Dominari Holdings Inc. (Nasdaq: DOMH) is pleased to announce…

12 hours ago

ISHI Health Launches Virtual Heart Failure Clinics in California and Arizona

SAN DIEGO, Dec. 12, 2025 /PRNewswire/ -- ISHI Health, an innovator in AI-enabled virtual cardiac…

12 hours ago

Zealthy Review 2026: How Zealthy Compares to FitRx and RoenRx for Weight Loss & GLP-1 Care

LOS ANGELES, CA / ACCESS Newswire / December 12, 2025 / The landscape of weight…

12 hours ago

Aspire Biopharma Granted Extension by Nasdaq Hearing Panel to Regain Compliance with Continued Listing Requirements

ESTERO, FL / ACCESS Newswire / December 12, 2025 / Aspire Biopharma Holdings, Inc. (Nasdaq:ASBP)…

12 hours ago